JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> BioPharma Services >> CDMO >> Services >> Small Molecules - DP Development & Manufacturing >> Micronization/Particle Size Reduction

Micronization/Particle Size Reduction

Sidebar Image

Micronization |Eurofins CDMO

Eurofins CDMO (Contract Development & Manufacturing Organization) network of companies offers micronization as a stand-alone or fully integrated service within API and Drug Product Operations. 

Our micronization development and GMP manufacturing services are supported by a dedicated team of scientists and state-of-the-art solid state laboratory. The pre-formulation and solid state teams work together using their expertise and proven track record to quickly advance programs from API through Drug Product Development.

Particle size reduction is one of the many tools available to our team to improve solubility and enhance the effectiveness of the drug. Based on your program needs, micronization can be performed as proof of concept at gram scale or at a larger GMP production scale.

Our Micronization services can help you:

  • Control particle size through the API and Drug Product development lifecycle
  • Perform solid state characterization to assess and control physicochemical properties
  • Conduct pre-formulation studies to evaluate solubility and permeability
  • Perform IND enabling API and Drug Product development
  • Perform clinical and commercial manufacturing for both non-potent and highly potent compounds
  • Integrate services that enables you to solve technical challenges in real time under one roof

 

Contact your CDMO expert >